top of page
RT Banners (1).png

We invite you to engage in an interactive nintely minute roundtable led by EverythingALS consortia of Pharma partners, sensor companies, neurologists, data scientists, regulators and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.


Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in EverythingALS research, which will be expanded to include analyzing data from wearables and smartphones.


As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below. 

This is an invite only event.


Hosts & Speakers 

  • Twitter
  • LinkedIn
  • Twitter
  • png-transparent-hyperlink-computer-icons-link-text-logo-number-removebg-preview
  • icons8-link-60
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • icons8-link-60
  • LinkedIn
RT Banners (2).png


Friday Sept 15, 2023 

     10:30AM - Noon ET   I   07:30 - 09:00AM PT

10 minutes

15 minutes

30 minutes

20 minutes

10 mins

5 mins

Welcome and Consortia Updates

Indu Navar - CEO and Founder, EverythingALS

Keynote : Family living with ALS

Sean and Dina Cellini Clancy will share with us the impact of ALS on family, and support and shared-decisions making

Research Learnings & Insights 

Speech Language Pathologist  (SLP) study - Dr. Lyle Ostrow 

Muti-modal Radcliff study walk through - Steve Kowalski & Stephanie Henze

Asymptomatic Carrier study - Indu Navar

Summit recap and next steps

Key takeaways from the July 24th Onsite Digital Biomarker summit 

By Josh Cosman, Bryan Hansen, Linus Sun & Christian Rubio

Discussion and Q&A

Looking Ahead and closing remarks - Indu Navar



bottom of page